Affera: Medtronic buying Affera for nearly $1B in deal for cardiac-mapping tech
Medtronic is starting off 2022 with a nearly $1 billion M&A deal, announcing its plan to buy Affera Inc., a maker of cardiac mapping and navigation tools and ablation technology used to treat atrial fibrillation.
Read full article »
Affera is a Massachusetts-based medical device company that manufactures and supplies products such as cardiac mapping and navigation systems for the healthcare industry.
Read more